A smartphone platform that monitors Parkinson's symptoms between doctor visits helped clinicians identify the need for earlier intervention in nearly 4 out of 5 patient encounters. The app, developed by Kneu Health and tested at Cedars-Sinai Medical Center, captured over 46,000 measurements of movement, speech, and cognitive function from 104 people with Parkinson's disease over six months, revealing symptom patterns that traditional clinic visits often miss. Why Daily Symptom Tracking Matters for Parkinson's Patients? Parkinson's disease is caused by the gradual loss of dopamine-producing nerve cells in the brain. Dopamine is the chemical messenger that controls smooth, coordinated movement, so as these cells deteriorate, patients experience tremors, stiffness, slowness, and balance problems. The challenge is that these symptoms fluctuate significantly from day to day, making it difficult for doctors to see the full picture during appointments that happen months apart. "As Parkinson's populations grow and clinical complexity increases, clinicians will need reliable visibility into how patients are progressing over time," explained Caroline Cake, co-founder and CEO of Kneu Health, in a company statement. Traditional clinic visits capture symptoms only at specific moments, meaning care adjustments often happen only after symptoms have already worsened significantly. The smartphone platform uses sensors and structured tests to track changes in tremor, voice, balance, gait, reaction time, and cognitive function. The system is designed to fit into patients' daily routines, providing a tool that can be used outside the clinic. Artificial intelligence models trained on clinical data help detect signs of neurological decline earlier and support more timely intervention. What Did the Cedars-Sinai Study Actually Find? During the six-month pilot program, researchers at Cedars-Sinai Medical Center analyzed the data to identify trends in symptom patterns and treatment response. The results were striking: in 79% of encounters, clinicians reported that the app prompted them to consider earlier intervention. In about half of the cases, the app revealed meaningful trends in symptoms over time. Additionally, clinicians reported a deeper understanding of disease progression in 93% of encounters. Perhaps most importantly, the app identified emerging nonmotor symptoms that patients may not report during clinic visits, including sleep disturbances and early memory changes. By integrating these measures into existing workflows, care teams can evaluate and address these issues more quickly. "Embedding sustained clinical insight into our Parkinson's program provides a more complete picture of how symptoms and treatments evolve between appointments. That additional visibility supports more timely adjustments and more personalized care planning across this complex patient population," said Michele Tagliati, MD, professor and neurologist at Cedars-Sinai Medical Center. How to Recognize When Parkinson's Symptoms Need Immediate Attention - Rest Tremor: A shaking that occurs when your hand or fingers are relaxed in your lap, which may lessen or disappear when you reach to pick something up. This is different from essential tremor, which occurs during action. - Slowness of Movement: Difficulty with everyday tasks like walking, writing, or buttoning clothes. This slowness, called bradykinesia, can manifest as a shuffling walk or difficulty initiating actions. - Muscle Stiffness: Persistent rigidity in the limbs or trunk that restricts movement and can cause muscle pain and limited range of motion. - Balance and Gait Changes: Poor posture, balance difficulties, or changes in the way you walk that interfere with daily activities. - Handwriting Changes: Progressive shrinking of handwriting, a condition called micrographia, which is a classic early sign of Parkinson's. The real-world impact of this technology is already evident in specific cases. In one example, progressive gait decline over six weeks was detected by the platform, prompting clinicians to conduct a detailed evaluation and consider a physiotherapy referral before a fall occurred. In another case, changes in tremor patterns suggested that an evening medication dose was becoming less effective, prompting clinicians to review treatment timing and possible factors affecting how the medication was absorbed. The smartphone-based digital tool that measures Parkinson's tremor has received FDA clearance and is expanding adoption across U.S. academic and specialty health systems, as well as several parts of the UK national health system. Last year, the company raised $5.6 million to expand the platform's commercial capacity, publish outcomes data, and advance dementia monitoring technology. This development represents a significant shift in how chronic neurological diseases are managed. Rather than waiting for symptoms to worsen between appointments, patients and their doctors now have access to continuous, objective data that can guide treatment decisions in real time. For people living with Parkinson's disease, this means the potential for better symptom control, fewer medication adjustments after crisis points, and ultimately, a better quality of life.
